Clinical Trial: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID
Study Status: Completed
Recruit Status: RECRUITING
Condition: Long Covid
Study Type: INTERVENTIONAL
Official Title: A Prospective, Double-blind, Randomized, Parallel Group, Placebo Controlled, Multicentre, Phase II Study to Investigate the Efficacy, GPCR Autoantibody Neutralizing Effect, Safety, and Tolerability of
Brief Summary:
This study is an interventional, randomized, multinational, multicenter, double-blind, phase 2 study with a follow-up period of circa 12 months.The intension of this clinical trial is to investigate the long-term sequelae (named Long COVID syndrome; post COVID or PASC) of an infection with Corona Virus Type 2 that has resulted in a condition known as Severe Acute Respiratory Syndrome Corona Virus Type 2 (SARS-CoV-2).The purpose of this study is to evaluate the efficacy and safety of BC 007 as a treatment for…
Read more